National Research Corporation (NRC)

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

National Research Corporation (NRC) is up 4.8% since the beginning of the year. At $19 per share, NRC is trading 14.5% below its 52-week high of $23. Investors who bought $1,000 worth of NRC shares 5 years ago would now be looking at an investment worth $495.

National Research Corporation (NRC) has returned 4.79% so far this year and 21.82% over the past 12 months. Over the last ten years, NRC has returned 5.66% per year, falling short of the S&P 500 Index benchmark, which averaged 13.88% annually.

Based on dividend-adjusted daily data since May 23, 2013, NRC's average daily return is +0.04%, while the average monthly return is +0.83%. At this rate, an investment would double in approximately 7.0 years.

Historically, 51% of months were positive and 49% were negative. The best month was May 2019 with a return of +28.8%, while the worst month was Feb 2026 at -34.1%. The longest winning streak lasted 6 consecutive months, and the longest losing streak was 5 months.

On a daily basis, NRC closed higher 51% of trading days. The best single day was Mar 19, 2020 with a return of +19.3%, while the worst single day was Mar 16, 2020 at -20.7%.

National Research Corporation has an annualized alpha of -0.97%, beta of 0.91, and R2 of 0.15 versus S&P 500 Index. Calculated based on daily prices since May 23, 2013.

• This stock participated in 119.91% of S&P 500 Index downside but only 76.30% of its upside - more exposed to losses than it benefited from rallies.
• R2 of 0.15 means this stock moves largely independently of S&P 500 Index - capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.

NRC ranks 54 for risk / return — on par with similar stocks. You're getting a typical balance of risk and reward. Not a standout, but not a red flag either — a reasonable choice if other factors align with your goals.

National Research Corporation provided a 2.87% dividend yield over the last twelve months, with an annual payout of $0.56 per share.

The table displays the monthly dividend distributions for National Research Corporation. The dividends shown in the table have been adjusted to account for any splits that may have occurred.

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.

The table below displays the maximum drawdowns of the National Research Corporation. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the National Research Corporation was 84.10%, occurring on Apr 21, 2025. The portfolio has not yet recovered.

The current National Research Corporation drawdown is 68.36%.

The chart below shows the rolling one-month volatility.

The chart below illustrates the trends in the financial health of National Research Corporation over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

The Valuation section provides an overview of how National Research Corporation is priced in the market compared to other companies in the Diagnostics & Research industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.